Literature DB >> 29949144

CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer.

N Liu1, J Zhang, L-Y Zhang, L Wang.   

Abstract

OBJECTIVE: CircRNAs have been recently identified as important regulators in tumors biological functions. However, the clinical significance of circHIPK3 in epithelial ovarian cancer (EOC) remains unknown. PATIENTS AND METHODS: The expression of circHIPK3 in EOC tumor tissues and adjacent noncancerous tissues was analyzed by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR). The association between circHIPK3 expression and clinicopathological factors was analyzed by using Chi-square test. Kaplan-Meier method and log-rank test were used to analyze the association of circHIPK3 expression with disease-free survival (DFS) and overall survival (OS) time of EOC patients. Univariate and multivariate Cox analysis was also performed.
RESULTS: We found that circHIPK3 was higher expressed in EOC tissues and cells compared to adjacent normal tissue and ovarian epithelium cell line, respectively. Higher circHIPK3 expression associated with lymph node invasion, FIGO stage, and worse DFS and OS of patients. Moreover, multivariate Cox analysis showed that higher circHIPK3 was an independent predictor of DFS and OS in EOC patients.
CONCLUSIONS: Thus, circHIPK3 may be a novel biomarker for predicting EOC prognosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29949144     DOI: 10.26355/eurrev_201806_15250

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  32 in total

Review 1.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

Review 2.  CircHIPK3: a promising cancer-related circular RNA.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Biogenesis, cellular effects, and biomarker value of circHIPK3.

Authors:  Yihan Fu; Hong Sun
Journal:  Cancer Cell Int       Date:  2021-05-11       Impact factor: 5.722

5.  Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion.

Authors:  Li Li; Qiaohua Zhang; Ke Lian
Journal:  Cancer Cell Int       Date:  2020-06-16       Impact factor: 5.722

6.  Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.

Authors:  D C Liu; L L Song; X Z Li; Q Liang; Z G Zhang; C H Han
Journal:  Clin Transl Oncol       Date:  2021-06-17       Impact factor: 3.405

Review 7.  Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.

Authors:  Shuna Liu; Ming Wu; Fang Wang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

Review 8.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

9.  Circular RNA circHIPK3 promotes breast cancer progression via sponging MiR-326.

Authors:  Na Luo; Shiqin Liu; Xin Li; Yu Hu; Kejing Zhang
Journal:  Cell Cycle       Date:  2021-06-21       Impact factor: 5.173

10.  circHIPK3 (hsa_circ_0000284) Promotes Proliferation, Migration and Invasion of Breast Cancer Cells via miR-326.

Authors:  Liqiang Qi; Bo Sun; Beibei Yang; Su Lu
Journal:  Onco Targets Ther       Date:  2021-06-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.